By continuing to browse the site you are agreeing to our policy on the use of cookies. In objective tests, fexofenadine has been shown to have no significant effects on central nervous system function. Do not remove fexofenadine ODT from the original blister package until the time of administration.
It is advisable to leave 2 hours between administration of fexofenadine hydrochloride and aluminium and magnesium hydroxide containing antacids.There are no adequate data from the use of fexofenadine hydrochloride in pregnant women.Limited animal studies do not indicate direct or indirect harmful effects with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development (see section 5.3)There are no data on the content of human milk after administering fexofenadine hydrochloride. The frequency with which they occur is not known (can not be estimated from available data)Hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxisInsomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria)Reporting suspected adverse reactions after authorisation of the medicinal product is important. However, the administration of an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to fexofenadine hydrochloride caused a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. However, when terfenadine was administered to nursing mothers fexofenadine was found to cross into human breast milk. There is no evidence of tolerance to these effects after 28 days of dosing. Coadministration of fexofenadine hydrochloride with erythromycin or ketoconazole has been found to result in a 2-3 times increase in the level of fexofenadine in plasma. Fexofenadine (Telfast®) is a non-drowsy antihistamine which is used to treat hay fever, skin allergies and other allergic symptoms. The recommended dose of fexofenadine hydrochloride for adolescents aged 12 years and over is 180 mg once daily taken before a meal. Special populations. Store fexofenadine ODT in its original blister package.
However, in order to identify sensitive people who have an unusual reaction to medicinal products, it is advisable to check the individual response before driving or performing complicated tasks.The following frequency rating has been used, when applicable:Not known (frequency cannot be estimated from the available data).Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo:In adults, the following undesirable effects have been reported in post-marketing surveillance. The single and multiple dose pharmacokinetics of fexofenadine are linear for oral doses up to 120 mg BID. 4.5 Interaction with other medicinal products and other forms of interaction6.6 Special precautions for disposal and other handling9. It allows continued monitoring of the benefit/risk balance of the medicinal product. The maximum tolerated dose of fexofenadine hydrochloride has not been established.Standard measures should be considered to remove any unabsorbed medicinal product. Continue typing to refine. The maximum tolerated dose of fexofenadine hydrochloride has not been established.Standard measures should be considered to remove any unabsorbed medicinal product. Fexofenadine hydrochloride should be administered with care in these special groups.Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and palpitations (see section 4.8).This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially 'sodium-free. You should take fexofenadine before a meal where possible. This information is intended for use by health professionalsFexofenadine Hydrochloride 120 mg film-coated tablets.Each film-coated tablet contains 120 mg of fexofenadine hydrochloride, which is equivalent to 112 mg of fexofenadine.Each film-coated tablet contains 7.495 mg of sodiumPeach coloured, oblong, biconvex, film coated tablets.Fexofenadine hydrochloride 120 mg tablet is indicated in adults and children 12 years and older for the relief of symptoms associated with seasonal allergic rhinitis.The recommended dose of fexofenadine hydrochloride for adults is 120 mg once daily taken before a meal.Fexofenadine is a pharmacologically active metabolite of terfenadine.The recommended dose of fexofenadine hydrochloride for adolescents aged 12 years and over is 120 mg once daily taken before a meal.The efficacy and safety of fexofenadine hydrochloride 120 mg has not been studied in children under 12.Studies in special risk groups (elderly, renally or hepatically impaired patients) indicate that it is not necessary to adjust the dose of fexofenadine hydrochloride in these patients.Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.As with most new medicinal products there is only limited data in the elderly and renally or hepatically impaired patients.